Expression and Signaling of Formyl-Peptide Receptors in the Brain

被引:81
作者
Cattaneo, Fabio [1 ]
Guerra, Germano [2 ]
Ammendola, Rosario [1 ]
机构
[1] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
[2] Univ Molise, Dipartimento Sci Salute, I-86100 Localita Tappino, Campobasso, Italy
关键词
Formyl-peptides receptors; Signal transduction; Cell cycle; Neuronal cells; Inhibitors of cyclins/CDK complexes; PROTEIN-COUPLED RECEPTOR; C5A CHEMOATTRACTANT RECEPTORS; HUMAN GLIOBLASTOMA CELLS; IMR90 HUMAN FIBROBLASTS; HUMAN PHAGOCYTIC-CELLS; FORMYLPEPTIDE RECEPTOR; N-FORMYLPEPTIDE; LIPOXIN A(4); MESANGIAL CELLS; NADPH-OXIDASE;
D O I
10.1007/s11064-010-0301-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human formyl-peptide receptor (FPR) and its variants FPRL1 and FPRL2 belong to the G-protein coupled seven transmembrane receptor (GPCR) family sensitive to pertussis toxin. FPR and FPRL1 were first detected in phagocytic leukocytes, and FPRL2 was found in monocytes and in dendritic cells. The three receptors were subsequently identified in other cell types or tissues, including neuronal cells and brain, where FPR and FPRL1 play a key role in angiogenesis, cell proliferation, protection against and cell death, as well as in neuroendocrine functions. Binding of different agonists to FPRs triggers several signaling pathways, activates NFkB and STAT3 transcriptional factors and induces the accumulation of the CDK inhibitors p21(waf1/cip1), p16(INK4) and p27(kip1). Signaling molecules, such as ERKs, JNK, PKC, p38MAPK, PLC and PLD are involved in these intracellular cascades. In this article we briefly review FPRs expression and signaling in neuronal cells.
引用
收藏
页码:2018 / 2026
页数:9
相关论文
共 70 条
[61]   Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation [J].
Wada, Koichiro ;
Arita, Makoto ;
Nakajima, Atsushi ;
Katayama, Kazufumi ;
Kudo, Chiho ;
Kamisaki, Yoshinori ;
Serhan, Charles N. .
FASEB JOURNAL, 2006, 20 (11) :1785-1792
[62]   A novel ligand of the formyl peptide receptor: Annexin I regulates neutrophil extravasation by interacting with the FPR [J].
Walther, A ;
Riehemann, K ;
Gerke, V .
MOLECULAR CELL, 2000, 5 (05) :831-840
[63]  
WENTELSEIFERT K, 1999, J BIOL CHEM, V264, P21470
[64]   Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor [J].
Wu, SH ;
Wu, XH ;
Lu, C ;
Dong, L ;
Chen, ZQ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (01) :65-72
[65]   Lipoxin A4 inhibits TNF-α-induced production of interleukins and proliferation of rat mesangial cells [J].
Wu, SH ;
Lu, C ;
Dong, L ;
Zhou, GP ;
He, ZG ;
Chen, ZQ .
KIDNEY INTERNATIONAL, 2005, 68 (01) :35-46
[66]   LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells [J].
Yang, D ;
Chen, Q ;
Schmidt, AP ;
Anderson, GM ;
Wang, JM ;
Wooters, J ;
Oppenheim, JJ ;
Chertov, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1069-1074
[67]   ISOLATION OF A CDNA THAT ENCODES A NOVEL GRANULOCYTE N-FORMYL PEPTIDE RECEPTOR [J].
YE, RD ;
CAVANAGH, SL ;
QUEHENBERGER, O ;
PROSSNITZ, ER ;
COCHRANE, CG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :582-589
[68]   Humanin, a newly identified neuroprotective factor, uses the g protein-coupled formylpeptide receptor-like-1 as a functional receptor [J].
Ying, GG ;
Iribarren, P ;
Zhou, Y ;
Gong, WH ;
Zhang, N ;
Yu, ZX ;
Le, Y ;
Cui, Y ;
Wang, JM .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :7078-7085
[69]   Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat [J].
Zhang, Y ;
Chan, MMK ;
Andrews, MC ;
Mori, TA ;
Croft, KD ;
McKenzie, KUS ;
Schyvens, CG ;
Whitworth, JA .
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (07) :910-916
[70]   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas [J].
Zhou, Y ;
Bian, XW ;
Le, YY ;
Gong, WH ;
Hu, JY ;
Zhang, X ;
Wang, LH ;
Iribarren, P ;
Salcedo, R ;
Howard, OMZ ;
Farrar, W ;
Wang, JM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (11) :823-835